STERIS plc (STE)
Healthcare · Medical - Specialties · Data as of 2026-09-01
Bottom line
STE is trading at a discount to its history, in the middle of its recent price range, and recent volume shows no clear direction. The picture is mixed, so it may be worth watching rather than acting on. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
STE trades at 29× earnings, below its own 5-year average of 49× and roughly in line with similar healthcare companies we track (29×, 52 peers). Historically this has been on the cheaper side for the stock. Its free-cash-flow yield is about 4.1%. Its current multiple sits around the 10th percentile of its own last five years — toward the low end of its own range. Its fundamentals scored 9 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — In the middle of its recent range (Yellow)
At $229.65, the stock sits between its recent support and resistance levels. Over the past year STE has traded between $195.14 and $269.44; its historical support zone sits near $224.11 and resistance near $233.35. It is above one of its moving averages and below the other — a mixed trend picture.
52-week range $195.14–$269.44 · 50-day average $224.11 · 200-day average $233.35
Money flow — No clear direction (Yellow)
Buying and selling volume in STE have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 0.8× volume on down days over the last 30 sessions.
About the company
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions.
一句话结论
STE 相对自身历史处于折价水平，处于近期价格区间的中部，近期成交量没有明确方向。整体情况好坏参半，也许更适合先观察，而不是急于行动。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
STE 目前的市盈率为 29×，低于其自身 5 年平均的 49×，并且大致持平于我们追踪的同类Healthcare公司（29×，52 家）。从历史来看，这属于该股较便宜的一侧。其自由现金流收益率约为 4.1%。它当前的估值倍数大约位于自身过去五年分布的第 10 百分位——处于自身区间的偏低位置。在一套标准的逐年基本面核对清单上，它 9 项中通过了 9 项——上一财年多数底层趋势在改善。
价格区间 — 处于近期区间的中部
目前价格为 $229.65，位于其近期的支撑位与阻力位之间。过去一年 STE 的价格在 $195.14 到 $269.44 之间波动；其历史支撑区在 $224.11 附近，阻力区在 $233.35 附近。它位于其中一条均线上方、另一条下方——趋势信号并不一致。
资金流向 — 方向不明确
STE 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 0.8×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.